Dental Implant Deal Activity Heating Up
Healthpoint Capital is making waves again in the dental implant industry. Fresh on the heels of their recent acquisition of BioHorizons, the private equity firm announced late last week that they were going to acquire publicly-traded BioLok for approximately $35 million.
"We have been successfully building our presence in the dental market,
which is one of the fastest growing sectors in the medical technology
industry," stated Mortimer Berkowitz III, President and Managing
Director of HealthpointCapital. "The addition of BioLok represents a
key point of our technology-driven strategy in the dental implant
industry. As BioLok has been experiencing growth which is well in
excess of the dental implant sector generally, we are very pleased to
have the entire BioLok team remain with the company to continue
executing on the growth strategy that has been impeccably implemented
for the past several years toward becoming a recognized and respected
global brand. Our mission is to continue unabated their passion for
excellence in the development and commercialization of high quality
dental products and servicing of dental practitioners."
It seems as if Healthpoint is trying to create a classic roll-up of sorts in
the dental implant industry and clearly they just might ignite a wave of more deals throughout the entire dental implant industry. The question of course is: Who will be the next acquisition candidate in the dental implant industry? But, of course, that’s for Wall Street to figure out. In the meantime, what are your thoughts on the recent deal activity in the dental implant industry? How will this change the current competitive landscape?
